CZ2002594A3 - Sférické aglomeráty telithromycinu, způsob jejich výroby a jejich použití při výrobě lékových forem - Google Patents

Sférické aglomeráty telithromycinu, způsob jejich výroby a jejich použití při výrobě lékových forem Download PDF

Info

Publication number
CZ2002594A3
CZ2002594A3 CZ2002594A CZ2002594A CZ2002594A3 CZ 2002594 A3 CZ2002594 A3 CZ 2002594A3 CZ 2002594 A CZ2002594 A CZ 2002594A CZ 2002594 A CZ2002594 A CZ 2002594A CZ 2002594 A3 CZ2002594 A3 CZ 2002594A3
Authority
CZ
Czechia
Prior art keywords
telithromycin
spherical agglomerates
agglomerates
spherical
particle size
Prior art date
Application number
CZ2002594A
Other languages
Czech (cs)
English (en)
Inventor
Jean-Yves Godard
Valérie Rognon-Ravaux
Original Assignee
Aventis Pharma S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CZ2002594(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S. A. filed Critical Aventis Pharma S. A.
Publication of CZ2002594A3 publication Critical patent/CZ2002594A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ2002594A 1999-08-26 2000-08-28 Sférické aglomeráty telithromycinu, způsob jejich výroby a jejich použití při výrobě lékových forem CZ2002594A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
CZ2002594A3 true CZ2002594A3 (cs) 2002-09-11

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ2002594A CZ2002594A3 (cs) 1999-08-26 2000-08-28 Sférické aglomeráty telithromycinu, způsob jejich výroby a jejich použití při výrobě lékových forem

Country Status (34)

Country Link
US (1) US6825218B1 (enExample)
EP (1) EP1212336B1 (enExample)
JP (1) JP4871467B2 (enExample)
KR (1) KR100718222B1 (enExample)
CN (1) CN1183151C (enExample)
AR (1) AR025398A1 (enExample)
AT (1) ATE255590T1 (enExample)
AU (1) AU774385B2 (enExample)
BR (1) BR0013569B1 (enExample)
CA (1) CA2382497C (enExample)
CO (1) CO5190666A1 (enExample)
CZ (1) CZ2002594A3 (enExample)
DE (1) DE60006976T2 (enExample)
DK (1) DK1212336T3 (enExample)
EA (1) EA005080B1 (enExample)
ES (1) ES2209970T3 (enExample)
FR (1) FR2797875B1 (enExample)
HK (1) HK1049167B (enExample)
HR (1) HRP20020167B1 (enExample)
HU (1) HU229075B1 (enExample)
IL (2) IL148128A0 (enExample)
ME (2) MEP20108A (enExample)
MX (1) MXPA02001988A (enExample)
NO (1) NO322622B1 (enExample)
PL (1) PL204100B1 (enExample)
PT (1) PT1212336E (enExample)
RS (1) RS50433B (enExample)
SI (1) SI1212336T1 (enExample)
SK (1) SK287588B6 (enExample)
TR (1) TR200200506T2 (enExample)
TW (1) TWI272949B (enExample)
UA (1) UA73523C2 (enExample)
WO (1) WO2001014393A2 (enExample)
ZA (1) ZA200201599B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
BR0215806A (pt) * 2002-07-19 2005-04-26 Aventis Pharma Sa Composição oral de telitromicina com paladar mascarado
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
EP1610878B1 (en) * 2003-02-21 2014-09-03 University Of Bath Process for the production of particles
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3468336D1 (en) * 1983-06-22 1988-02-11 Univ Ohio State Res Found Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
AU7018100A (en) 2001-03-19
CA2382497C (fr) 2011-06-28
SK287588B6 (sk) 2011-03-04
SK2532002A3 (en) 2002-09-10
HK1049167B (zh) 2005-08-19
US6825218B1 (en) 2004-11-30
FR2797875B1 (fr) 2001-10-19
IL148128A (en) 2006-10-31
ATE255590T1 (de) 2003-12-15
UA73523C2 (uk) 2005-08-15
HUP0202842A3 (en) 2003-03-28
WO2001014393A3 (fr) 2001-06-21
KR100718222B1 (ko) 2007-05-15
NO20020926L (no) 2002-02-26
DK1212336T3 (da) 2004-03-15
CN1183151C (zh) 2005-01-05
DE60006976T2 (de) 2004-10-21
PL353137A1 (en) 2003-10-20
KR20020033771A (ko) 2002-05-07
HUP0202842A2 (hu) 2003-01-28
JP4871467B2 (ja) 2012-02-08
YU13202A (sh) 2004-09-03
CO5190666A1 (es) 2002-08-29
CA2382497A1 (fr) 2001-03-01
MEP20108A (en) 2010-06-10
CN1371386A (zh) 2002-09-25
BR0013569A (pt) 2002-05-14
ME00112B (me) 2010-10-10
RS50433B (sr) 2009-12-31
ES2209970T3 (es) 2004-07-01
AR025398A1 (es) 2002-11-27
TR200200506T2 (tr) 2002-08-21
EA005080B1 (ru) 2004-10-28
MXPA02001988A (es) 2002-08-20
PT1212336E (pt) 2004-04-30
HK1049167A1 (en) 2003-05-02
ZA200201599B (en) 2003-04-30
HRP20020167B1 (en) 2006-06-30
DE60006976D1 (de) 2004-01-15
WO2001014393A2 (fr) 2001-03-01
TWI272949B (en) 2007-02-11
FR2797875A1 (fr) 2001-03-02
PL204100B1 (pl) 2009-12-31
IL148128A0 (en) 2002-09-12
EP1212336A2 (fr) 2002-06-12
HU229075B1 (hu) 2013-07-29
BR0013569B1 (pt) 2014-02-25
NO20020926D0 (no) 2002-02-26
HRP20020167A2 (en) 2003-06-30
SI1212336T1 (en) 2004-04-30
EP1212336B1 (fr) 2003-12-03
NO322622B1 (no) 2006-11-06
AU774385B2 (en) 2004-06-24
JP2003507484A (ja) 2003-02-25
EA200200294A1 (ru) 2002-08-29

Similar Documents

Publication Publication Date Title
US8658212B2 (en) Pharmaceutical composition containing fenofibrate and method for the preparation thereof
IL142787A (en) Coated particles of granulated crystalline ibuprofen
UA117465C2 (uk) Продукт cпівмікронізації, який включає ацетат уліпристалу
AU774385B2 (en) Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms
RU2288218C2 (ru) Формы гатифлоксацина для применения в педиатрии
AU2002345534A1 (en) Pediatric formulation of gatifloxacin
CZ299182B6 (cs) Vícedávková farmaceutická kompozice v tuhé perorální forme s rízeným uvolnováním, výhodne ve forme tablet nebo tvrdých želatinových kapslí s obsahem chloridu draselného
CA2885798A1 (en) Crystalline polymorphic form of ulipristal acetate
AU2013321890B2 (en) Crystalline polymorphic form of ulipristal acetate
TW201522360A (zh) 烏普司他醋酸之結晶多晶型